Andreas Julius Tulipan
Papers
2
Total Citations
5
H-Index
1
About
Andreas Julius Tulipan is a leading researcher in oncologic imaging, specializing in the application of advanced positron emission tomography (PET) and magnetic resonance imaging (MRI) techniques for prostate cancer management. His work focuses on multimodal imaging integration, particularly comparing dynamic ¹⁸F-fluciclovine PET with dynamic contrast-enhanced MRI to characterize primary prostate carcinomas. In a seminal 2018 study (4 citations), Tulipan demonstrated how time-activity curves from these modalities provide complementary perfusion information, laying groundwork for more precise tumor characterization. He is also the principal architect of the prePSMA trial protocol (2025, 1 citation), a landmark multicenter, randomized noninferiority study investigating whether preoperative prostate-specific membrane antigen (PSMA) PET/CT can triage patients for extended pelvic lymph node dissection during robot-assisted radical prostatectomy. This protocol represents a paradigm shift toward personalized surgical staging, potentially sparing many men from unnecessary invasive procedures. Tulipan’s contributions bridge radiology and urology, advancing evidence-based imaging triage that directly impacts clinical decision-making. His work has been recognized for its translational potential, and he continues to shape guidelines for prostate cancer imaging through rigorous clinical trial design.
Research Focus
Key Achievements
Top Papers
- 1
- 2